-

Middle East and North Africa Pay TV Forecasts - Revenue is Expected to Recover by 2025 by Reaching $1,269 Million - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Middle East and North Africa Pay TV Forecasts" report has been added to ResearchAndMarkets.com's offering.

Pay-TV revenues for the 20 countries in the Middle East and North Africa region fell by 12% between 2016 and 2019 to just under $3 billion.

Given the hangover from the beIN ban and generally falling ARPUs, revenues in 2025 ($2.81 billion) will still be lower than in 2019.

For the 13 Arabic-speaking countries, pay-TV revenues fell by 15% from $1,241 million in 2016 to $1,053 million in 2019.

However, the total will recover to reach $1,269 million by 2025.

Pay-TV subscriptions fell by 5% between 2016 and 2019 to 3.58 million, but will progress to 4.71 million by 2025.

Key Topics Covered:

Published in January 2020, this 182-page PDF and excel report is the ninth edition.

The report comes in three parts:

  • Outlook: Forecasts for 20 countries in a 45-page PowerPoint document full of charts, graphs and bullet points;
  • Excel workbook covering each year from 2010 to 2025 for 20 countries by household penetration, by pay TV subscribers, by pay TV revenues and by major operator. As well as summary tables by country and by platform;
  • Insight: Detailed country-by-country analysis in a 57-page PDF document.

Companies Mentioned

  • Algerie Telecom
  • Alma
  • Batelco
  • beIN
  • D-Smart
  • Digiturk
  • Du
  • eLife
  • HOT
  • Invision
  • KT
  • Magtisat
  • Maroc Telecom
  • Mobily
  • Omantel
  • Ooredoo
  • Orange
  • OSN
  • Sliknet
  • Telecom Egypt
  • TTNet
  • Turkcell
  • Turksat
  • Uzdigital
  • Uztelecom
  • Yes

For more information about this report visit https://www.researchandmarkets.com/r/y68pqn

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom